TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic …

K Iljin, M Wolf, H Edgren, S Gupta, S Kilpinen… - Cancer research, 2006 - AACR
Translocations fusing the strong androgen-responsive gene, TMPRSS2, with ERG or other
oncogenic ETS factors may facilitate prostate cancer development. Here, we studied 18 …
被引用次数：307 相关文章

[引用][C] TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic …

K Iljin, M Wolf, H Edgren, S Gupta, S Kilpinen… - 2006 - repository.ubn.ru.nl
TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic
rearrangements and are associated with HDAC1 and epigenetic reprogramming. Toggle …

[引用][C] TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic …

K Iljin, M Wolf, H Edgren, S Gupta… - Cancer …, 2006 - researchportal.helsinki.fi
TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic
rearrangements and are associated with HDAC1 and epigenetic reprogramming — University …
[PDF] academia.edu

[PDF][PDF] TMPRSS2 Fusions with Oncogenic ETS Factors in Prostate Cancer Involve Unbalanced Genomic Rearrangements and Are Associated with HDAC1 and …

K Iljin, M Wolf, H Edgren, S Gupta, S Kilpinen… - academia.edu
Translocations fusing the strong androgen-responsive gene, TMPRSS2, with ERG or other
oncogenic ETS factors may facilitate prostate cancer development. Here, we studied 18 …

TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic …

K Iljin, M Wolf, H Edgren, S Gupta… - Cancer …, 2006 - pubmed.ncbi.nlm.nih.gov
Translocations fusing the strong androgen-responsive gene, TMPRSS2, with ERG or other
oncogenic ETS factors may facilitate prostate cancer development. Here, we studied 18 …

[引用][C] TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic …

K ILJIN, M WOLF, M NEES… - Cancer research …, 2006 - pascal-francis.inist.fr
TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic
rearrangements and are associated with HDAC1 and epigenetic reprogramming CNRS Inist …
[PDF] semanticscholar.org

[PDF][PDF] TMPRSS2 Fusions with Oncogenic ETS Factors in Prostate Cancer Involve Unbalanced Genomic Rearrangements and Are Associated with HDAC1 and …

K Iljin, M Wolf, H Edgren, S Gupta, S Kilpinen… - pdfs.semanticscholar.org
Translocations fusing the strong androgen-responsive gene, TMPRSS2, with ERG or other
oncogenic ETS factors may facilitate prostate cancer development. Here, we studied 18 …

TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic …

K Iljin, M Wolf, H Edgren, S Gupta, S Kilpinen… - Cancer …, 2006 - europepmc.org
Translocations fusing the strong androgen-responsive gene, TMPRSS2, with ERG or other
oncogenic ETS factors may facilitate prostate cancer development. Here, we studied 18 …
[PDF] researchgate.net

[PDF][PDF] TMPRSS2 Fusions with Oncogenic ETS Factors in Prostate Cancer Involve Unbalanced Genomic Rearrangements and Are Associated with HDAC1 and …

K Iljin, M Wolf, H Edgren, S Gupta, S Kilpinen… - researchgate.net
Translocations fusing the strong androgen-responsive gene, TMPRSS2, with ERG or other
oncogenic ETS factors may facilitate prostate cancer development. Here, we studied 18 …

TMPRSS2 Fusions with Oncogenic ETS Factors in Prostate Cancer Involve Unbalanced Genomic Rearrangements and Are Associated with HDAC1 and Epigenetic …

K Iljin, M Wolf, H Edgren, S Gupta, S Kilpinen… - Cancer …, 2006 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Translocations fusing the strong androgen-
responsive gene, TMPRSS2, with ERG or other oncogenic ETS factors may facilitate …